188 related articles for article (PubMed ID: 26356797)
1. BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients.
Rossi F; Li X; Jacobson L; Levine AJ; Chen Y; Palella FJ; Margolick J; Viscidi R
Virology; 2015 Nov; 485():467-72. PubMed ID: 26356797
[TBL] [Abstract][Full Text] [Related]
2. Association Between BKPyV Serotype I Antibody Level and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Rossi F; Prosperini L; De Rossi N; Capra R; Rivanera D; Li X; Cinque P; Passeri L; Pozzilli C; Viscidi R
Viral Immunol; 2017 Oct; 30(8):622-626. PubMed ID: 28836899
[TBL] [Abstract][Full Text] [Related]
3. Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling.
Kardas P; Leboeuf C; Hirsch HH
J Clin Virol; 2015 Oct; 71():28-33. PubMed ID: 26370311
[TBL] [Abstract][Full Text] [Related]
4. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
[TBL] [Abstract][Full Text] [Related]
5. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
6. JC and BK polyomavirus-specific immunoglobulin G responses in patients thymectomized in early childhood.
Prelog M; Egli A; Zlamy M; Hirsch HH
J Clin Virol; 2013 Nov; 58(3):553-8. PubMed ID: 24055269
[TBL] [Abstract][Full Text] [Related]
7. JC Polyomavirus Infection of Primary Human Renal Epithelial Cells Is Controlled by a Type I IFN-Induced Response.
Assetta B; De Cecco M; O'Hara B; Atwood WJ
mBio; 2016 Jul; 7(4):. PubMed ID: 27381292
[TBL] [Abstract][Full Text] [Related]
8. Serum IgG antibodies from healthy subjects up to 100 years old react to JC polyomavirus.
Bononi I; Mazzoni E; Pietrobon S; Manfrini M; Torreggiani E; Rossini M; Lotito F; Guerra G; Rizzo P; Martini F; Tognon M
J Cell Physiol; 2018 Aug; 233(8):5513-5522. PubMed ID: 29323725
[TBL] [Abstract][Full Text] [Related]
9. Antibody against synthetic multiple antigen peptides (MAP) of JC virus capsid protein (VP1) without cross reaction to BK virus: a diagnostic tool for progressive multifocal leukoencephalopathy.
Aoki N; Mori M; Kato K; Sakamoto Y; Noda K; Tajima M; Shimada H
Neurosci Lett; 1996 Feb; 205(2):111-4. PubMed ID: 8907329
[TBL] [Abstract][Full Text] [Related]
10. Footprints of BK and JC polyomaviruses in specimens from females affected by spontaneous abortion.
Tagliapietra A; Rotondo JC; Bononi I; Mazzoni E; Magagnoli F; Maritati M; Contini C; Vesce F; Tognon M; Martini F
Hum Reprod; 2019 Mar; 34(3):433-440. PubMed ID: 30590693
[TBL] [Abstract][Full Text] [Related]
11. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus.
Viscidi RP; Rollison DE; Sondak VK; Silver B; Messina JL; Giuliano AR; Fulp W; Ajidahun A; Rivanera D
Clin Vaccine Immunol; 2011 Oct; 18(10):1737-43. PubMed ID: 21880855
[TBL] [Abstract][Full Text] [Related]
12. Detection and analysis of variants of JC polyomavirus in urine samples from HIV-1-infected patients in China's Zhejiang Province.
Hu C; Huang Y; Su J; Wang M; Zhou Q; Zhu B
J Int Med Res; 2018 Mar; 46(3):1024-1032. PubMed ID: 29322824
[TBL] [Abstract][Full Text] [Related]
13. Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors.
Tan CS; Ghofrani J; Geiger E; Koralnik IJ; Jost S
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):220-224. PubMed ID: 31513076
[TBL] [Abstract][Full Text] [Related]
14. Preparation of monoclonal antibodies to JC virus and their use in the diagnosis of progressive multifocal leucoencephalopathy.
Knowles WA; Sharp IR; Efstratiou L; Hand JF; Gardner SD
J Med Virol; 1991 Jun; 34(2):127-31. PubMed ID: 1653819
[TBL] [Abstract][Full Text] [Related]
15. BK and JC polyomavirus infections in Tunisian renal transplant recipients.
Boukoum H; Nahdi I; Sahtout W; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
J Med Virol; 2015 Oct; 87(10):1788-95. PubMed ID: 25952258
[TBL] [Abstract][Full Text] [Related]
16. Occurrence, genotypic characterization, and patterns of shedding of human polyomavirus JCPyV and BKPyV in urine samples of healthy individuals in São Paulo, Brazil.
Urbano PR; Oliveira RR; Romano CM; Pannuti CS; Fink MC
J Med Virol; 2016 Jan; 88(1):153-8. PubMed ID: 26147595
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers.
Knowles WA; Pillay D; Johnson MA; Hand JF; Brown DW
J Med Virol; 1999 Dec; 59(4):474-9. PubMed ID: 10534729
[TBL] [Abstract][Full Text] [Related]
18. Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy.
Diotti RA; Mancini N; Clementi N; Sautto G; Moreno GJ; Criscuolo E; Cappelletti F; Man P; Forest E; Remy L; Giannecchini S; Clementi M; Burioni R
Antiviral Res; 2014 Aug; 108():94-103. PubMed ID: 24909571
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of renal transplant recipients reveals an absence of primary JC polyomavirus infections.
Saundh BK; Baker R; Harris M; Hale A
J Clin Virol; 2016 Apr; 77():101-5. PubMed ID: 26923352
[TBL] [Abstract][Full Text] [Related]
20. Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy - a realistic possibility?
Jelcic I; Combaluzier B; Jelcic I; Sospedra M; Grimm J; Martin R
Swiss Med Wkly; 2017; 147():w14520. PubMed ID: 29120025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
